Affiance Financial’s Clorox CLX Stock Holding History

Affiance Financial’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-307	Closed	-$43.1K	–	154
2022 Q4	$43.1K	Buy	+307	New	+$43.6K	0.02%	177

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Affiance Financial's CLX Position: Q1 2023 in Review

Affiance Financial sold out of Clorox (CLX) in Q1 2023, closing a stake of 307 shares — an estimated $43.1K sold.

Affiance Financial first reported a position in CLX in Q4 2022 and held it in 1 quarter. The position peaked at $43.1K in Q4 2022. 1,139 funds tracked by Wall St. Rank hold CLX as of Q1 2023.

Affiance Financial reported no remaining Clorox position as of Q1 2023 after selling out during the quarter.
Affiance Financial sold 307 Clorox shares in Q1 2023, an estimated $43.1K.
Affiance Financial first reported a position in Clorox in Q4 2022 and held it in 1 quarter.
Affiance Financial's Clorox position peaked at $43.1K in Q4 2022.
1,139 funds tracked by Wall St. Rank held Clorox as of Q1 2023.

Based on Affiance Financial's 13F filing for Q1 2023, filed 18 Apr 2023.